Form 4 for GNLX GENELUX Corp
Accepted 2024-12-20 00:00:00 ET · period of report 2024-12-18 · accession 0001415889-24-030007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-20 | 2024-12-18 | GNLX | Smalling Ralph | Head of Regulatory | A - Grant | $0.00 | +15.5K | 31.8K | +95% | $0 |
| D | 2024-12-20 | 2024-12-18 | GNLX | Smalling Ralph | Head of Regulatory | A - Grant | $0.00 | +21.1K | 21.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-18 | A | A | 15,525 | $0.00 | 31,847 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-12-18 | A | A | 21,100 | $0.00 | 21,100 | D | $2.29 · — to 2034-12-17 | 21,100 Common Stock | (F2) 25% of the shares vest on August 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter. |